Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwe (Q36512803)
Jump to navigation
Jump to search
scientific article published on 18 October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwe |
scientific article published on 18 October 2007 |
Statements
1 reference
Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwe (English)
1 reference
Southwest Oncology Group
1 reference
David S Alberts
1 reference
P Y Liu
1 reference
Sharon P Wilczynski
1 reference
Mary C Clouser
1 reference
Ana Maria Lopez
1 reference
David P Michelin
1 reference
Victor J Lanzotti
1 reference
Maurie Markman
1 reference
18 October 2007
1 reference
1 reference
90-94
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference